BIO-key International (BKYI) 10-Q 14 Aug 24 2024 Q2 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	6 Months Ended
	Jun. 30, 2024	Aug. 13, 2024
Document Information [Line Items]
Entity Central Index Key	0001019034
Entity Registrant Name	BIO KEY INTERNATIONAL INC
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2024
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2024
Document Transition Report	false
Entity File Number	1-13463
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	41-1741861
Entity Address, Address Line One	101 CRAWFORDS CORNER ROAD, SUITE 4116
Entity Address, City or Town	HOLMDEL
Entity Address, State or Province	NJ
Entity Address, Postal Zip Code	07733
City Area Code	732
Local Phone Number	359-1100
Title of 12(b) Security	Common Stock, par value $0.0001 per share
Trading Symbol	BKYI
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		1,982,201

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)	Jun. 30, 2024	Dec. 31, 2023
ASSETS
Cash and cash equivalents	$ 1,260,351	$ 511,400
Accounts receivable, net	904,046	1,201,526
Due from factor	28,164	99,320
Inventory	433,182	445,740
Prepaid expenses and other	388,786	364,171
Total current assets	3,014,529	2,622,157
Equipment and leasehold improvements, net	174,419	220,177
Capitalized contract costs, net	348,617	229,806
Operating lease right-of-use assets	9,341	36,905
Intangible assets, net	1,252,090	1,407,990
Total non-current assets	1,784,467	1,894,878
TOTAL ASSETS	4,798,996	4,517,035
LIABILITIES
Accounts payable	1,539,548	1,316,014
Accrued liabilities	1,164,681	1,305,848
Deferred revenue, current	715,193	414,968
Operating lease liabilities, current portion	9,570	37,829
Total current liabilities	5,574,685	3,213,389
Deferred revenue, long term	142,949	28,296
Deferred tax liability	22,998	22,998
Government loan – BBVA Bank – net of current portion	114,656	188,787
Total non-current liabilities	280,603	240,081
TOTAL LIABILITIES	5,855,288	3,453,470
Commitments and Contingencies
STOCKHOLDERS’ EQUITY
Common stock — authorized, 170,000,000 shares; issued and outstanding; 1,815,618 and 1,032,777 of $.0001 par value at June 30, 2024 and December 31, 2023, respectively	182	103
Additional paid-in capital	126,143,205	126,047,851
Accumulated other comprehensive loss	(15,234)	22,821
Accumulated deficit	(127,184,445)	(125,007,210)
TOTAL STOCKHOLDERS’ EQUITY	(1,056,292)	1,063,565
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	4,798,996	4,517,035
Senior Secured Promissory Note [Member]
LIABILITIES
Debt, current	2,010,293	0
Government Loan [Member]
LIABILITIES
Debt, current	$ 135,400	$ 138,730

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - $ / shares	Jun. 30, 2024	Dec. 31, 2023
Common stock, shares authorized (in shares)	170,000,000	170,000,000
Common stock, shares issued (in shares)	1,815,618	1,032,777
Common stock, shares outstanding (in shares)	1,815,618	1,032,777
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Revenues
Revenues	$ 1,141,286	$ 1,928,929	$ 3,322,489	$ 4,112,696
Costs and other expenses
Cost of Goods and Services Sold	262,272	1,606,111	561,915	2,926,385
Gross profit	879,014	322,818	2,760,574	1,186,311
Operating Expenses
Selling, general and administrative	1,941,866	2,143,164	3,724,839	4,074,896
Research, development and engineering	591,234	558,181	1,198,755	1,248,340
Total Operating Expenses	2,533,100	2,701,345	4,923,594	5,323,236
Operating loss	(1,654,086)	(2,378,527)	(2,163,020)	(4,136,925)
Other income (expense)
Interest income	46	23	51	27
Loss on foreign currency transactions	0	0	0	(15,000)
Loan fee amortization	(4,000)	0	(4,000)	0
Change in fair value of convertible note	0	(44,568)	0	97,423
Interest expense	(8,910)	(56,806)	(10,267)	(113,725)
Total other income (expense), net	(12,864)	(101,351)	(14,216)	(31,275)
Loss before provision for income tax	(1,666,950)	(2,479,878)	(2,177,236)	(4,168,200)
Provision for (income tax) tax benefit	0	(143,000)	0	(143,000)
Net loss	(1,666,950)	(2,622,878)	(2,177,236)	(4,311,200)
Comprehensive loss:
Net loss	(1,666,950)	(2,622,878)	(2,177,236)	(4,311,200)
Other comprehensive income (loss) – Foreign currency translation adjustment	24,220	19,884	(38,530)	92,030
Comprehensive loss	$ (1,642,730)	$ (2,602,994)	$ (2,215,766)	$ (4,219,170)
Basic and Diluted Loss per Common Share (in dollars per share)	$ (1)	$ (4.71)	$ (1.33)	$ (7.74)
Weighted Average Common Shares Outstanding:
Basic and diluted (in shares)	1,663,042	556,758	1,639,183	556,758
Service [Member]
Revenues
Revenues	$ 283,569	$ 620,465	$ 496,690	$ 1,152,987
Costs and other expenses
Cost of Goods and Services Sold	73,385	360,156	212,234	514,957
License [Member]
Revenues
Revenues	774,225	1,235,771	2,724,659	2,814,327
Costs and other expenses
Cost of Goods and Services Sold	148,432	198,147	296,652	819,028
Hardware [Member]
Revenues
Revenues	83,492	72,693	101,140	145,382
Costs and other expenses
Cost of Goods and Services Sold	40,455	47,808	53,029	92,400
Hardware Reserve [Member]
Costs and other expenses
Cost of Goods and Services Sold	$ 0	$ 1,000,000	$ 0	$ 1,500,000

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	AOCI Attributable to Parent [Member]	Retained Earnings [Member]	Total
Balance (in shares) at Dec. 31, 2022	552,739
Balance at Dec. 31, 2022	$ 55	$ 122,029,476	$ (242,602)	$ (116,485,373)	$ 5,301,556
Issuance of common stock for directors’ fees (in shares)	855
Issuance of common stock for directors’ fees	$ 0	12,002	0		12,002
Issuance of common stock to employees	$ 0	4	0	0	4
Restricted stock forfeited (in shares)	(1,102)
Restricted stock forfeited	$ 0	3,105	0	0	3,105
Other comprehensive income (loss) – Foreign currency translation adjustment	0	0	72,146	0	72,146
Share-based compensation	0	62,474	0	0	62,474
Net loss	$ 0	0	0	(1,688,322)	(1,688,322)
Issuance of common stock to employees (in shares)	2,222
Restricted stock forfeited	$ 0	(3,105)	0	0	(3,105)
Balance (in shares) at Mar. 31, 2023	554,714
Balance at Mar. 31, 2023	$ 55	122,100,851	(170,456)	(118,173,695)	3,756,755
Balance (in shares) at Dec. 31, 2022	552,739
Balance at Dec. 31, 2022	$ 55	122,029,476	(242,602)	(116,485,373)	5,301,556
Other comprehensive income (loss) – Foreign currency translation adjustment					92,030
Net loss					(4,311,200)
Balance (in shares) at Jun. 30, 2023	556,758
Balance at Jun. 30, 2023	$ 55	122,192,181	(150,572)	(120,796,573)	1,245,091
Balance (in shares) at Mar. 31, 2023	554,714
Balance at Mar. 31, 2023	$ 55	122,100,851	(170,456)	(118,173,695)	3,756,755
Issuance of common stock for directors’ fees (in shares)	1,286
Issuance of common stock for directors’ fees	$ 0	16,002	0		16,002
Restricted stock forfeited (in shares)	(799)
Restricted stock forfeited	$ 0	0	0	0	0
Other comprehensive income (loss) – Foreign currency translation adjustment	0	0	19,884	0	19,884
Share-based compensation	0	57,831	0	0	57,831
Net loss	$ 0	0	0	(2,622,878)	(2,622,878)
Issuance of common stock for Employee stock purchase plan (in shares)	1,557
Issuance of common stock for Employee stock purchase plan	$ 0	13,934	0	0	13,934
Share based compensation for employee stock plan	0	3,563	0	0	3,563
Restricted stock forfeited	$ 0	0	0	0	0
Balance (in shares) at Jun. 30, 2023	556,758
Balance at Jun. 30, 2023	$ 55	122,192,181	(150,572)	(120,796,573)	1,245,091
Balance (in shares) at Dec. 31, 2023	1,032,777
Balance at Dec. 31, 2023	$ 103	126,047,851	22,821	(125,007,210)	1,063,565
Issuance of common stock for directors’ fees (in shares)	4,287
Issuance of common stock for directors’ fees	$ 0	9,003	0		9,003
Issuance of common stock to employees	$ 0	0	0	0	0
Restricted stock forfeited (in shares)	(316)
Restricted stock forfeited	$ 0	0	0	0	0
Exercise of warrants (in shares)	777,666
Exercise of warrants	$ 78	1,322	0	0	1,400
Other comprehensive income (loss) – Foreign currency translation adjustment	0		(62,275)	0	(62,275)
Share-based compensation	0	47,790	0	0	47,790
Issuance costs	0	(13,470)	0	0	(13,470)
Net loss	0	0	0	(510,285)	(510,285)
Restricted stock forfeited	$ 0	0	0	0	0
Balance (in shares) at Mar. 31, 2024	1,814,414
Balance at Mar. 31, 2024	$ 181	126,092,496	(39,454)	(125,517,495)	535,728
Balance (in shares) at Dec. 31, 2023	1,032,777
Balance at Dec. 31, 2023	$ 103	126,047,851	22,821	(125,007,210)	1,063,565
Other comprehensive income (loss) – Foreign currency translation adjustment					(38,530)
Net loss					(2,177,236)
Balance (in shares) at Jun. 30, 2024	1,815,618
Balance at Jun. 30, 2024	$ 182	126,143,205	(15,234)	(127,184,445)	(1,056,292)
Balance (in shares) at Mar. 31, 2024	1,814,414
Balance at Mar. 31, 2024	$ 181	126,092,496	(39,454)	(125,517,495)	535,728
Restricted stock forfeited (in shares)	(186)
Restricted stock forfeited	$ 0	0	0	0	0
Other comprehensive income (loss) – Foreign currency translation adjustment	0	0	24,220	0	24,220
Share-based compensation	0	48,315	0	0	48,315
Net loss	$ 0	0	0	(1,666,950)	(1,666,950)
Issuance of common stock for Employee stock purchase plan (in shares)	1,390
Issuance of common stock for Employee stock purchase plan	$ 1	1,938	0	0	1,939
Share based compensation for employee stock plan	0	456	0	0	456
Restricted stock forfeited	$ 0	0	0	0	0
Balance (in shares) at Jun. 30, 2024	1,815,618
Balance at Jun. 30, 2024	$ 182	$ 126,143,205	$ (15,234)	$ (127,184,445)	$ (1,056,292)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
CASH FLOW FROM OPERATING ACTIVITIES:
Net loss	$ (2,177,236)	$ (4,311,200)
Adjustments to reconcile net loss to net cash used for operating activities:
Depreciation	46,069	26,637
Amortization of intangible assets	155,900	162,166
Change in fair value of convertible note	0	(97,423)
Amortization of capitalized contract costs	80,074	80,717
Reserve for inventory	0	1,500,000
Operating leases right-of-use assets	27,564	112,745
Share and warrant-based compensation for employees and consultants	96,561	120,767
Stock based directors’ fees	9,003	28,004
Deferred income tax benefit	0	(13,000)
Bad debts	0	250,000
Change in assets and liabilities:
Accounts receivable	297,480	(757,170)
Due from factor	71,156	(24,750)
Capitalized contract costs	(198,885)	(75,096)
Inventory	12,558	50,271
Prepaid expenses and other	(24,615)	14,799
Accounts payable	258,384	726,657
Accrued liabilities	(141,167)	(109,208)
Income taxes payable	0	156,000
Deferred revenue	414,878	174,437
Operating lease liabilities	(51,257)	(110,545)
Net cash used in operating activities	(1,123,533)	(2,095,192)
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures	(1,869)	0
Net cash used in investing activities	(1,869)	0
CASH FLOW FROM FINANCING ACTIVITIES:
Proceeds from Note Payable	2,000,000	0
Offering costs	(13,470)	0
Proceeds for exercise of warrants	1,400	0
Receipt of cash from Employee stock purchase plan	1,939	13,934
Repayment of government loan	(77,461)	(56,241)
Net cash used in financing activities	1,912,408	(42,307)
Effect of exchange rate changes	(38,055)	67,490
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	748,951	(2,070,009)
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	511,400	2,635,522
CASH AND CASH EQUIVALENTS, END OF PERIOD	1,260,351	565,513
Cash paid for:
Interest	$ 3,974	$ 56,919

Note 1 - Nature of Business and

Note 1 - Nature of Business and Basis of Presentation	6 Months Ended
	Jun. 30, 2024
Notes to Financial Statements
Business Description and Accounting Policies [Text Block]	1. NATURE OF BUSINESS AND BASIS OF PRESENTATION Nature of Business The Company, founded in 1993, Basis of Presentation The accompanying unaudited interim condensed consolidated financial statements include the accounts of BIO-key International, Inc. and its wholly-owned subsidiaries (collectively, the “Company” or “BIO-key”) and are stated in conformity with accounting principles generally accepted in the United States of America (“GAAP”), pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). The operating results for interim periods are not may In the opinion of management, the accompanying unaudited interim consolidated financial statements contain all necessary adjustments, consisting only of those of a recurring nature, and disclosures to present fairly the Company’s financial position and the results of its operations and cash flows for the periods presented. The balance sheet at June 30, 2024 not 10 December 31, 2023 June 5, 2024. Foreign Currencies The Company accounts for foreign currency transactions pursuant to ASC 830, Foreign Currency Matters 830” 830, Recently Issued Accounting Pronouncements Effective January 1, 2023, 2016 13, Financial Instruments-Credit Losses 326 2016 13, not 2016 13 2016 13 no not may not 2016 13. 2016 13 In August 2020, 2020 06, Debt with Conversion and Other Options (Subtopic 470 20 s Own Equity (Subtopic 815 40 2020 06” 2020 06 2020 06 2020 06 January 1, 2024 2016 13 not Management does not not

Note 2 - Going Concern

Note 2 - Going Concern	6 Months Ended
	Jun. 30, 2024
Notes to Financial Statements
Substantial Doubt about Going Concern [Text Block]	2. GOING CONCERN The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America ("GAAP"), which contemplate continuation of the Company as a going concern, and assumes continuity of operations, realization of assets and the satisfaction of liabilities and commitments in the normal course of business. The Company has suffered substantial net losses and negative cash flows from operations in recent years and is dependent on debt and equity financing to fund its operations all of which raise substantial doubt about the Company’s ability to continue as a going concern. Recoverability of a major portion of the recorded asset amounts shown in the accompanying balance sheet is dependent upon the Company’s ability to increase its revenue and meet its financing requirements on a continuing basis and become profitable in its future operations. The accompanying consolidated financial statements do not As of the date of this report, the Company does not twelve

Note 3 - Revenue From Contracts

Note 3 - Revenue From Contracts With Customers	6 Months Ended
	Jun. 30, 2024
Notes to Financial Statements
Revenue from Contract with Customer [Text Block]	3. REVENUE FROM CONTRACTS WITH CUSTOMERS Disaggregation of Revenue The following table summarizes revenue from contracts with customers for the three June 30, 2024 June 30, 2023 North June 30, America Africa EMESA* Asia 2024 License fees $ 539,625 $ - $ 234,600 $ - $ 774,225 Hardware 70,292 - - 13,200 83,492 Services 238,759 43,423 1,387 - 283,569 Total Revenues $ 848,676 $ 43,423 $ 235,987 $ 13,200 $ 1,141,286 North June 30, America Africa EMESA* Asia 2023 License fees $ 780,383 $ - $ 455,388 $ - $ 1,235,771 Hardware 61,551 - 142 11,000 72,693 Services 281,607 26,009 305,424 7,425 620,465 Total Revenues $ 1,123,541 $ 26,009 $ 760,954 $ 18,425 $ 1,928,929 The following table summarizes revenue from contracts with customers for the six June 30, 2024 June 30, 2023 North June 30, America Africa EMESA* Asia 2024 Services $ 430,239 $ 63,677 $ 2,774 $ - $ 496,690 License fees 1,058,869 1,266,553 399,237 - 2,724,659 Hardware 87,701 - 239 13,200 101,140 Total Revenues $ 1,576,809 $ 1,330,230 $ 402,250 $ 13,200 $ 3,322,489 North June 30, America Africa EMESA* Asia 2023 Services $ 545,464 $ 49,797 $ 545,351 $ 12,375 $ 1,152,987 License fees 1,188,913 552,630 1,002,134 70,650 2,814,327 Hardware 86,332 - 47,150 11,900 145,382 Total Revenues $ 1,820,709 $ 602,427 $ 1,594,635 $ 94,925 $ 4,112,696 *EMESA – Europe, Middle East, South America Deferred Revenue Deferred revenue includes customer advances and amounts that have been paid by customer for which the contractual maintenance terms have not 12 June 30, 2024 December 31, 2023 three six June 30, 2024 three six June 30, 2023

Note 4 - Accounts Receivable

Note 4 - Accounts Receivable	6 Months Ended
	Jun. 30, 2024
Notes to Financial Statements
Loans, Notes, Trade and Other Receivables Disclosure [Text Block]	4. ACCOUNTS RECEIVABLE Accounts receivable are carried at original amount less an estimate made for credit losses based on a review of all outstanding amounts on a monthly basis. Management determines the allowance for credit losses by regularly evaluating individual customer receivables and considering a customer’s financial condition, credit history, current economic conditions and other relevant factors, including specific reserves for certain accounts. Accounts receivable are written off when deemed uncollectible. Accounts receivable at June 30, 2024 December 31, 2023 June 30, December 31, 2024 2023 Accounts receivable $ 1,543,002 $ 2,207,311 Allowance for credit losses (638,956 ) (1,005,785 ) Accounts receivable, net of allowances for credit losses $ 904,046 $ 1,201,526 Bad debt expenses are recorded in selling, general, and administrative expense.

Note 5 - Share Based Compensati

Note 5 - Share Based Compensation	6 Months Ended
	Jun. 30, 2024
Notes to Financial Statements
Share-Based Payment Arrangement [Text Block]	5. SHARE BASED COMPENSATION The following table presents share-based compensation expenses included in the Company’s unaudited condensed interim consolidated statements of operations: Three Months Ended June 30, 2024 2023 Selling, general and administrative $ 39,383 $ 59,966 Research, development and engineering 9,388 17,430 $ 48,771 $ 77,396 Six Months Ended June 30, 2024 2023 Selling, general and administrative $ 87,025 $ 115,419 Research, development and engineering 18,539 33,352 $ 105,564 $ 148,771

Note 6 - Inventory

Note 6 - Inventory	6 Months Ended
	Jun. 30, 2024
Notes to Financial Statements
Inventory Disclosure [Text Block]	6. INVENTORY Inventory is stated at the lower of cost, determined on a first first June 30, 2024 December 31, 2023 June 30, December 31, 2024 2023 Finished goods $ 4,360,526 $ 4,373,056 Fabricated assemblies 59,156 59,184 Reserve on finished goods (3,986,500 ) (3,986,500 ) Total inventory $ 433,182 $ 445,740

Note 7 - Commitments and Contin

Note 7 - Commitments and Contingencies	6 Months Ended
	Jun. 30, 2024
Notes to Financial Statements
Commitments Disclosure [Text Block]	7. COMMITMENTS AND CONTINGENCIES Distribution Agreement Swivel Secure has a distribution agreement with Swivel Secure Limited (“SSL”). Terms of the agreement include the following: 1. The initial term of the agreement ends on January 31, 2027 one not 30 not 2. SSL appoints Swivel Secure as the exclusive distributor of SSL’s products, to market, sell and distribute in the EMEA (Europe, Middle East and Africa), excluding the United Kingdom and Republic of Ireland, for a defined discount on the sale price. 3. Swivel Secure is expected to generate a certain minimum level of orders of SSL products each year during the term of the agreement. If Swivel Secure fails to meet such minimum level of orders in any year, the exclusive distribution rights will terminate and Swivel Secure will serve as a non-exclusive distributer of SSL Products. The Company expects the revenue targets to continue to be met based on historical performance and increasing distribution by Swivel Secure. Litigation From time to time, the Company may June 30, 2024 not

Note 8 - Leases

Note 8 - Leases	6 Months Ended
	Jun. 30, 2024
Notes to Financial Statements
Lessee, Operating Leases [Text Block]	8. LEASES The Company’s leases office space in New Jersey, Minnesota, New Hampshire, Madrid and Hong-Kong with lease termination dates in 2024. August 11, 2023, one September 1, 2023 3 Months ended 3 Months ended June 30, June 30, 2024 2023 Lease cost Total lease cost $ 14,553 $ 48,543 6 Months ended 6 Months ended June 30, June 30, 2024 2023 Lease cost Total lease cost $ 29,106 $ 111,682 June 30, December 31, Balance sheet information 2024 2023 Operating right-of-use assets $ 9,341 $ 36,905 Operating lease liabilities, current portion $ 9,570 $ 37,829 Operating lease liabilities, non-current portion - - Total operating lease liabilities $ 9,570 $ 37,829 Weighted average remaining lease term (in years) – operating leases 0.17 0.67 Weighted average discount rate – operating leases 5.50 % 5.50 % Cash paid for amounts included in the measurement of operating lease liabilities for the six months ended June 30, 2024 and 2023: $ 22,613 $ 69,821 Maturities of operating lease liabilities were as follows as of June 30, 2024 2024 (2 months remaining) $ 9,702 2025 - Total future lease payments $ 9,702 Less: imputed interest (132 ) Total $ 9,570

Note 9 - Note Payable

Note 9 - Note Payable	6 Months Ended
	Jun. 30, 2024
Notes to Financial Statements
Long-Term Debt [Text Block]	9. N OTE PAYABLE Note Purchase Agreement dated June 24, 2024 On June 24, 2024, “2024 2024 2024 2024 eighteen 2024 nine 2024 seven six 2024 three 3 not 2024 fifth 5th one 2024 2024 forty 2024 The 2024 may ( twenty two 2024 fifteen 2024 five 2024 not twenty five

Note 10 - Convertible Note Paya

Note 10 - Convertible Note Payable	6 Months Ended
	Jun. 30, 2024
Notes to Financial Statements
Debt Disclosure [Text Block]	10. CONVERTIBLE NOTE PAYABLE Securities Purchase Agreement dated December 22, 2022 On December 22, 2022, The principal amount of the Note was due six one six six seven In connection with the issuance of the Note, the Company issued to the investor 38,889 shares of Common Stock (the “Commitment Shares”) valued at $18.00 per share and a warrant (the “Warrant”) to purchase 11,112 shares of common stock (the “Warrant Shares”) at an exercise price of $54.00 per share, exercisable commencing on the date of issuance with a term of five On October 31, 2023 December 21, 2023 As of December 31, 2023

Note 11 - Earnings (Loss) Per S

Note 11 - Earnings (Loss) Per Share - Common Stock ("EPS")	6 Months Ended
	Jun. 30, 2024
Notes to Financial Statements
Earnings Per Share [Text Block]	11. EARNINGS (LOSS) PER SHARE - COMMON STOCK (“EPS”) The Company’s basic EPS is calculated using net income (loss) available to common shareholders and the weighted-average number of shares outstanding during the reporting period. Diluted EPS includes the effect from potential issuance of common stock, such as stock issuable pursuant to the exercise of stock options and warrants and the assumed conversion of preferred stock. The following table sets forth options and warrants which were excluded from the diluted per share calculation because the exercise price was greater than the average market price of the common shares: Three Months ended Six Months Ended June 30, June 30, 2024 2023 2024 2023 Stock options 3,373 9,628 3,373 9,628 Warrants 1,722,695 270,672 1,722,695 270,672 Total 1,726,068 280,300 1,726,068 280,300

Note 12 - Stockholders' Equity

Note 12 - Stockholders' Equity	6 Months Ended
	Jun. 30, 2024
Notes to Financial Statements
Equity [Text Block]	12. STOCKHOLDERS’ EQUITY Issuances of Common Stock During the six June 30, 2024 2023 not Issuances to Directors, Executive Officers & Consultants On June 18, 2021, first may June 17, 2031. June 28, 2024, June 30, 2023, Issuances of Restricted Stock Restricted stock consists of shares of common stock that are subject to restrictions on transfer and risk of forfeiture until the fulfillment of specified conditions. The fair value of nonvested shares is determined based on the market price of the Company's common stock on the grant date. Nonvested stock is expensed ratably over the term of the restriction period. During the six June 30, 2024 2023 three During the six June 30, 2024 2023 Share based compensation for the six June 30, 2024 2023 Issuances to Directors During the six June 30, 2024 2023 Employees ’ exercise options During the six June 30, 2024 2023 no 3. There were no six June 30, 2024 2023 three March 31, 2024.

Note 13 - Fair Values of Financ

Note 13 - Fair Values of Financial Instruments	6 Months Ended
	Jun. 30, 2024
Notes to Financial Statements
Fair Value Disclosures [Text Block]	13. FAIR VALUES OF FINANCIAL INSTRUMENTS Cash and cash equivalents, accounts receivable, due from factor, accounts payable and accrued liabilities are carried at, or approximate, fair value because of their short-term nature. The carrying value of the Company’s government loan payable approximates fair value as the interest rate related to the financial instruments approximated market.

Note 14 - Major Customers and A

Note 14 - Major Customers and Accounts Receivable	6 Months Ended
	Jun. 30, 2024
Notes to Financial Statements
Concentration Risk Disclosure [Text Block]	14. MAJOR CUSTOMERS During each of the three June 30, 2024 2023 10% one six June 30, 2024 2023 one Two customers accounted for 94% of current accounts receivable at June 30, 2024 December 31, 2023 one

Note 16 - Income Taxes

Note 16 - Income Taxes	6 Months Ended
	Jun. 30, 2024
Notes to Financial Statements
Income Tax Disclosure [Text Block]	15. INCOME TAXES United States, Hong Kong and Nigeria The Company recorded no three six June 30, 2024 2023 As of June 30, 2024 December 31, 2023 not not Spain Due to the current loss for the six June 30, 2024 not

Note 16 - Subsequent Events

Note 16 - Subsequent Events	6 Months Ended
	Jun. 30, 2024
Notes to Financial Statements
Subsequent Events [Text Block]	16 SUBSEQUENT EVENTS During July 2024, On July 31, 2024, three On July 31, 2024, three The Company has reviewed subsequent events through the date of this filing.

Insider Trading Arrangements

Insider Trading Arrangements	6 Months Ended
	Jun. 30, 2024
Insider Trading Arr Line Items
Material Terms of Trading Arrangement [Text Block]	5. During the six June 30, 2024 none 16a 1 1934, 10b5 1 10b5 1 408
Rule 10b5-1 Arrangement Adopted [Flag]	false
Non-Rule 10b5-1 Arrangement Adopted [Flag]	false
Rule 10b5-1 Arrangement Terminated [Flag]	false
Non-Rule 10b5-1 Arrangement Terminated [Flag]	false

Significant Accounting Policies

Significant Accounting Policies (Policies)	6 Months Ended
	Jun. 30, 2024
Accounting Policies [Abstract]
Basis of Accounting, Policy [Policy Text Block]	Basis of Presentation The accompanying unaudited interim condensed consolidated financial statements include the accounts of BIO-key International, Inc. and its wholly-owned subsidiaries (collectively, the “Company” or “BIO-key”) and are stated in conformity with accounting principles generally accepted in the United States of America (“GAAP”), pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). The operating results for interim periods are not may In the opinion of management, the accompanying unaudited interim consolidated financial statements contain all necessary adjustments, consisting only of those of a recurring nature, and disclosures to present fairly the Company’s financial position and the results of its operations and cash flows for the periods presented. The balance sheet at June 30, 2024 not 10 December 31, 2023 June 5, 2024.
Foreign Currency Transactions and Translations Policy [Policy Text Block]	Foreign Currencies The Company accounts for foreign currency transactions pursuant to ASC 830, Foreign Currency Matters 830” 830,
New Accounting Pronouncements, Policy [Policy Text Block]	Recently Issued Accounting Pronouncements Effective January 1, 2023, 2016 13, Financial Instruments-Credit Losses 326 2016 13, not 2016 13 2016 13 no not may not 2016 13. 2016 13 In August 2020, 2020 06, Debt with Conversion and Other Options (Subtopic 470 20 s Own Equity (Subtopic 815 40 2020 06” 2020 06 2020 06 2020 06 January 1, 2024 2016 13 not Management does not not

Note 3 - Revenue From Contrac_2

Note 3 - Revenue From Contracts With Customers (Tables)	6 Months Ended
	Jun. 30, 2024
Notes Tables
Disaggregation of Revenue [Table Text Block]	North June 30, America Africa EMESA* Asia 2024 License fees $ 539,625 $ - $ 234,600 $ - $ 774,225 Hardware 70,292 - - 13,200 83,492 Services 238,759 43,423 1,387 - 283,569 Total Revenues $ 848,676 $ 43,423 $ 235,987 $ 13,200 $ 1,141,286 North June 30, America Africa EMESA* Asia 2023 License fees $ 780,383 $ - $ 455,388 $ - $ 1,235,771 Hardware 61,551 - 142 11,000 72,693 Services 281,607 26,009 305,424 7,425 620,465 Total Revenues $ 1,123,541 $ 26,009 $ 760,954 $ 18,425 $ 1,928,929 North June 30, America Africa EMESA* Asia 2024 Services $ 430,239 $ 63,677 $ 2,774 $ - $ 496,690 License fees 1,058,869 1,266,553 399,237 - 2,724,659 Hardware 87,701 - 239 13,200 101,140 Total Revenues $ 1,576,809 $ 1,330,230 $ 402,250 $ 13,200 $ 3,322,489 North June 30, America Africa EMESA* Asia 2023 Services $ 545,464 $ 49,797 $ 545,351 $ 12,375 $ 1,152,987 License fees 1,188,913 552,630 1,002,134 70,650 2,814,327 Hardware 86,332 - 47,150 11,900 145,382 Total Revenues $ 1,820,709 $ 602,427 $ 1,594,635 $ 94,925 $ 4,112,696

Note 4 - Accounts Receivable (T

Note 4 - Accounts Receivable (Tables)	6 Months Ended
	Jun. 30, 2024
Notes Tables
Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]	June 30, December 31, 2024 2023 Accounts receivable $ 1,543,002 $ 2,207,311 Allowance for credit losses (638,956 ) (1,005,785 ) Accounts receivable, net of allowances for credit losses $ 904,046 $ 1,201,526

Note 5 - Share Based Compensa_2

Note 5 - Share Based Compensation (Tables)	6 Months Ended
	Jun. 30, 2024
Notes Tables
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]	Three Months Ended June 30, 2024 2023 Selling, general and administrative $ 39,383 $ 59,966 Research, development and engineering 9,388 17,430 $ 48,771 $ 77,396 Six Months Ended June 30, 2024 2023 Selling, general and administrative $ 87,025 $ 115,419 Research, development and engineering 18,539 33,352 $ 105,564 $ 148,771

Note 6 - Inventory (Tables)

Note 6 - Inventory (Tables)	6 Months Ended
	Jun. 30, 2024
Notes Tables
Schedule of Inventory, Current [Table Text Block]	June 30, December 31, 2024 2023 Finished goods $ 4,360,526 $ 4,373,056 Fabricated assemblies 59,156 59,184 Reserve on finished goods (3,986,500 ) (3,986,500 ) Total inventory $ 433,182 $ 445,740

Note 8 - Leases (Tables)

Note 8 - Leases (Tables)	6 Months Ended
	Jun. 30, 2024
Notes Tables
Lessee, Operating Lease, Costs, Assets and Liabilities [Table Text Block]	3 Months ended 3 Months ended June 30, June 30, 2024 2023 Lease cost Total lease cost $ 14,553 $ 48,543 6 Months ended 6 Months ended June 30, June 30, 2024 2023 Lease cost Total lease cost $ 29,106 $ 111,682 June 30, December 31, Balance sheet information 2024 2023 Operating right-of-use assets $ 9,341 $ 36,905 Operating lease liabilities, current portion $ 9,570 $ 37,829 Operating lease liabilities, non-current portion - - Total operating lease liabilities $ 9,570 $ 37,829 Weighted average remaining lease term (in years) – operating leases 0.17 0.67 Weighted average discount rate – operating leases 5.50 % 5.50 % Cash paid for amounts included in the measurement of operating lease liabilities for the six months ended June 30, 2024 and 2023: $ 22,613 $ 69,821 2024 (2 months remaining) $ 9,702 2025 - Total future lease payments $ 9,702 Less: imputed interest (132 ) Total $ 9,570

Note 11 - Earnings (Loss) Per_2

Note 11 - Earnings (Loss) Per Share - Common Stock ("EPS") (Tables)	6 Months Ended
	Jun. 30, 2024
Notes Tables
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]	Three Months ended Six Months Ended June 30, June 30, 2024 2023 2024 2023 Stock options 3,373 9,628 3,373 9,628 Warrants 1,722,695 270,672 1,722,695 270,672 Total 1,726,068 280,300 1,726,068 280,300

Note 3 - Revenue From Contrac_3

Note 3 - Revenue From Contracts With Customers (Details Textual) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Contract with Customer, Liability	$ 858,000		$ 858,000		$ 443,000
Contract with Customer, Liability, Revenue Recognized	$ 157,000	$ 102,000	$ 431,000	$ 335,000
Minimum [Member]
Capitalized Contract Cost, Amortization Period (Month)	12 months		12 months
Maximum [Member]
Capitalized Contract Cost, Amortization Period (Month)	60 months		60 months

Note 3 - Revenue From Contrac_4

Note 3 - Revenue From Contracts With Customers - Disaggregation of Revenue (Details) - USD ($)		3 Months Ended		6 Months Ended
		Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Revenues		$ 1,141,286	$ 1,928,929	$ 3,322,489	$ 4,112,696
North America [Member]
Revenues		848,676	1,123,541	1,576,809	1,820,709
Africa [Member]
Revenues		43,423	26,009	1,330,230	602,427
EMESA [Member]
Revenues	[1]	235,987	760,954	402,250	1,594,635
Asia [Member]
Revenues		13,200	18,425	13,200	94,925
License [Member]
Revenues		774,225	1,235,771	2,724,659	2,814,327
License [Member] | North America [Member]
Revenues		539,625	780,383	1,058,869	1,188,913
License [Member] | Africa [Member]
Revenues		0	0	1,266,553	552,630
License [Member] | EMESA [Member]
Revenues	[1]	234,600	455,388	399,237	1,002,134
License [Member] | Asia [Member]
Revenues		0	0	0	70,650
Service [Member]
Revenues		283,569	620,465	496,690	1,152,987
Service [Member] | North America [Member]
Revenues		238,759	281,607	430,239	545,464
Service [Member] | Africa [Member]
Revenues		43,423	26,009	63,677	49,797
Service [Member] | EMESA [Member]
Revenues	[1]	1,387	305,424	2,774	545,351
Service [Member] | Asia [Member]
Revenues		0	7,425	0	12,375
Hardware [Member]
Revenues		83,492	72,693	101,140	145,382
Hardware [Member] | North America [Member]
Revenues		70,292	61,551	87,701	86,332
Hardware [Member] | Africa [Member]
Revenues		0	0	0	0
Hardware [Member] | EMESA [Member]
Revenues	[1]	0	142	239	47,150
Hardware [Member] | Asia [Member]
Revenues		$ 13,200	$ 11,000	$ 13,200	$ 11,900
[1]EMESA – Europe, Middle East, South America

Note 4 - Accounts Receivable -

Note 4 - Accounts Receivable - Summary of Accounts Receivable (Details) - USD ($)	Jun. 30, 2024	Dec. 31, 2023
Accounts receivable	$ 1,543,002	$ 2,207,311
Allowance for credit losses	(638,956)	(1,005,785)
Accounts receivable, net of allowances for credit losses	$ 904,046	$ 1,201,526

Note 5 - Share Based Compensa_3

Note 5 - Share Based Compensation - Expenses for Continuing Operations (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Share-based compensation expense	$ 48,771	$ 77,396	$ 105,564	$ 148,771
Selling, General and Administrative Expenses [Member]
Share-based compensation expense	39,383	59,966	87,025	115,419
Research and Development Expense [Member]
Share-based compensation expense	$ 9,388	$ 17,430	$ 18,539	$ 33,352

Note 6 - Inventory (Details Tex

Note 6 - Inventory (Details Textual)	Jun. 30, 2024 USD ($)
NIGERIA
Inventory Valuation Reserves	$ 3,300,000

Note 6 - Inventory - Components

Note 6 - Inventory - Components of Inventory (Details) - USD ($)	Jun. 30, 2024	Dec. 31, 2023
Finished goods	$ 4,360,526	$ 4,373,056
Fabricated assemblies	59,156	59,184
Reserve on finished goods	(3,986,500)	(3,986,500)
Total inventory	$ 433,182	$ 445,740

Note 8 - Leases (Details Textua

Note 8 - Leases (Details Textual)	Aug. 11, 2023
Office Space in New Jersey [Member]
Lessee, Operating Lease, Term of Contract (Year)	1 year

Note 8 - Leases - Operating Lea

Note 8 - Leases - Operating Lease Balance Sheet Information (Details) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Total lease cost	$ 14,553	$ 48,543	$ 29,106	$ 111,682
Operating lease right-of-use assets	9,341		9,341		$ 36,905
Operating lease liabilities, current portion	9,570		9,570		37,829
Operating lease liabilities, non-current portion	0		0		$ 0
Total operating lease liabilities	$ 9,570		$ 9,570
Weighted average remaining lease term (in years) – operating leases (Year)	2 months 1 day		2 months 1 day		8 months 1 day
Weighted average discount rate – operating leases	5.50%		5.50%		5.50%
Cash paid for amounts included in the measurement of operating lease liabilities for the six months ended June 30, 2024 and 2023:			$ 22,613		$ 69,821
2024 (2 months remaining)	$ 9,702		9,702
2025	0		0
Total future lease payments	9,702		9,702
Less: imputed interest	(132)		(132)
Total	9,570		9,570
Approximation [Member]
Operating lease right-of-use assets	9,341		9,341		36,905
Total operating lease liabilities	9,570		9,570		37,829
Total	$ 9,570		$ 9,570		$ 37,829

Note 9 - Note Payable (Details

Note 9 - Note Payable (Details Textual) - USD ($)		6 Months Ended
	Jun. 24, 2024	Jun. 30, 2024	Jun. 30, 2023
Proceeds from Debt, Net of Issuance Costs		$ 2,000,000	$ 0
The 2024 Note [Member] | Senior Secured Promissory Note [Member]
Debt Instrument, Face Amount	$ 2,360,000
Debt Instrument, Unamortized Discount	350,000
Payments of Financing Costs	10,000
Proceeds from Debt, Net of Issuance Costs	$ 2,000,000
Debt Instrument, Term (Month)	18 months
Debt Instrument, Interest Rate, Stated Percentage	9%
Debt Instrument, Exit Fee Percentage	7%
Debt Instrument, Redemption Amount	$ 270,000
Debt Instrument, Reduction in Outstanding Balance at The End Of Each Month	$ 270,000
Debt Instrument, Mandatory Prepayment, Percentage	40%
The 2024 Note [Member] | Senior Secured Promissory Note [Member] | Debt Instrument, Event of Default [Member]
Debt Instrument, Interest Rate, Stated Percentage	22%
Debt Instrument, Increase (Decrease), Percentage	1%
Debt Instrument Interest Rate, MajorTrigger Event		15%
The 2024 Note [Member] | Senior Secured Promissory Note [Member] | Maximum [Member]
Debt Instrument, Redemption Amount	$ 270,000
The 2024 Note [Member] | Senior Secured Promissory Note [Member] | Maximum [Member] | Debt Instrument, Event of Default [Member]
Debt Instrument, Interest Rate, Stated Percentage		25%
The 2024 Note [Member] | Senior Secured Promissory Note [Member] | Minimum [Member] | Debt Instrument, Event of Default [Member]
Debt Instrument Interest Rate, Minor Trigger Event		5%

Note 10 - Convertible Note Pa_2

Note 10 - Convertible Note Payable (Details Textual) - USD ($)				6 Months Ended
	Dec. 21, 2023	Oct. 31, 2023	Dec. 22, 2022	Jun. 30, 2024	Jun. 30, 2023
Proceeds from Debt, Net of Issuance Costs				$ 2,000,000	$ 0
Class of Warrant or Right, Issued During Period (in shares)				0	0
Warrants Issued in Connection with Convertible Notes [Member]
Class of Warrant or Right, Issued During Period (in shares)			11,112
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)			$ 54
Warrants and Rights Outstanding, Term (Year)			5 years
Warrants and Rights Outstanding			$ 94,316
The Note [Member]
Repayments of Notes Payable	$ 800,000	$ 1,400,000
The Note [Member] | Senior Secured Promissory Note [Member]
Debt Instrument, Face Amount			2,200,000
Proceeds from Debt, Net of Issuance Costs			$ 2,002,000
Debt Instrument, Interest Rate, Stated Percentage			10%	12%
Stock Issued During Period, Shares, Commitment Fees (in shares)			38,889
Shares Issued, Price Per Share (in dollars per share)			$ 18

Note 11 - Earnings (Loss) Per_3

Note 11 - Earnings (Loss) Per Share - Common Stock ("EPS") - Securities Excluded From the Diluted Per Share Calculation (Details) - Exercise Price Greater Than Average Market Price Of Common Shares [Member] - shares	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Antidilutive securities (in shares)	1,726,068	280,300	1,726,068	280,300
Share-Based Payment Arrangement, Option [Member]
Antidilutive securities (in shares)	3,373	9,628	3,373	9,628
Warrant [Member]
Antidilutive securities (in shares)	1,722,695	270,672	1,722,695	270,672

Note 12 - Stockholders' Equity

Note 12 - Stockholders' Equity (Details Textual) - USD ($)				3 Months Ended				6 Months Ended
	Jun. 28, 2024	Jun. 30, 2023	Jun. 18, 2021	Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2024	Jun. 30, 2023
Share-Based Payment Arrangement, Expense				$ 48,771		$ 77,396		$ 105,564	$ 148,771
Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture					$ 9,003	$ 16,002	$ 12,002
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period (in shares)								0	0
Class of Warrant or Right, Issued During Period (in shares)								0	0
Pre-Funded Warrants [Member]
Class of Warrant or Right, Exercised During Period (in shares)					777,666
Common Stock [Member]
Stock Issued During Period, Shares, Employee Stock Purchase Plans (in shares)				1,390		1,557
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures (in shares)							2,222
Stock Issued During Period, Shares, Restricted Stock Award, Forfeited (in shares)				186	316	799	1,102
Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture (in shares)					4,287	1,286	855
Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture					$ 0	$ 0	$ 0
Common Stock [Member] | Director [Member]
Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture (in shares)								4,287	2,141
Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture								$ 9,003	$ 28,004
Restricted Stock [Member]
Share-Based Payment Arrangement, Expense								$ 96,561	$ 120,767
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures (in shares)								0	2,222
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)								3 years	3 years
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Granted in Period, Fair Value								$ 0	$ 31,200
Stock Issued During Period, Shares, Restricted Stock Award, Forfeited (in shares)								502	1,901
Employee Stock Purchase Plan [Member]
Common Stock, Capital Shares Reserved for Future Issuance (in shares)			43,334
Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent			85%
Stock Issued During Period, Shares, Employee Stock Purchase Plans (in shares)	1,390	1,557
Share-Based Payment Arrangement, Expense	$ 456	$ 3,563

Note 14 - Major Customers and_2

Note 14 - Major Customers and Accounts Receivable (Details Textual) - Customer Concentration Risk [Member]	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Revenue Benchmark [Member]
Concentration Risk, Number of Major Customers	0	0
Revenue Benchmark [Member] | One Customer [Member]
Concentration Risk, Number of Major Customers	1	1	1
Concentration Risk, Percentage	12%	12%	40%
Revenue Benchmark [Member] | Two Customers [Member]
Concentration Risk, Number of Major Customers				2
Concentration Risk, Percentage				30%
Accounts Receivable [Member] | One Customer [Member]
Concentration Risk, Number of Major Customers					1
Concentration Risk, Percentage					35%
Accounts Receivable [Member] | Two Customers [Member]
Concentration Risk, Number of Major Customers			2
Concentration Risk, Percentage			94%

Note 16 - Income Taxes (Details

Note 16 - Income Taxes (Details Textual) - USD ($) Pure in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Income Tax Expense (Benefit)	$ 0	$ 143,000	$ 0	$ 143,000
United States, Hong Kong, and Nigeria [Member]
Income Tax Expense (Benefit)	$ 0	$ 0	$ 0	$ 0
Effective Income Tax Rate Reconciliation, Percent	0%	0%	0%	0%
SPAIN
Income Tax Expense (Benefit)			$ 0

Note 16 - Subsequent Events (De

Note 16 - Subsequent Events (Details Textual) - shares		1 Months Ended	6 Months Ended
	Jul. 31, 2024	Jul. 31, 2024	Jun. 30, 2024	Jun. 30, 2023
Common Stock [Member] | Subsequent Event [Member] | Director [Member]
Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture (in shares)	1,352
Common Stock [Member] | Share-Based Payment Arrangement, Employee [Member] | Subsequent Event [Member]
Shares Issued, Shares, Share-Based Payment Arrangement, Forfeited (in shares)		849
Restricted Stock [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)			3 years	3 years
Restricted Stock [Member] | Subsequent Event [Member] | Director [Member]
Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture (in shares)	10,500
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)	3 years
Restricted Stock [Member] | Share-Based Payment Arrangement, Employee [Member] | Subsequent Event [Member]
Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture (in shares)	158,486
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)	3 years